Visa Acquires AI Fraud Firm BioCatch for $2.4 Billion to Counter Global Scam Wave
Visa announces $2.4B all-cash acquisition of BioCatch, an AI behavioral biometrics leader protecting 1.8B devices across 350+ banks, as AI-powered fraud costs the global economy over $1 trillion annually.
Capital One Discloses AML Probe Behind Trump Organization Account Closures: Investor Implications for COF
Capital One formally disclosed its anti-money laundering rationale for closing 300+ Trump Organization accounts in a landmark August 1 court filing. The disclosure creates dual legal-regulatory risk for COF as it integrates Discover Financial — and may set a precedent for how U.S. banks must publicly defend AML compliance decisions.
AstraZeneca Explores $400B Bristol-Myers Squibb Mega-Merger: Antitrust, Oncology, and What It Means for Korean CDMOs
Bloomberg and the Financial Times report that AstraZeneca has held preliminary discussions about acquiring Bristol-Myers Squibb in a deal that could create a $400 billion pharmaceutical giant. The combination would face three-jurisdiction antitrust review, while Korean CDMO Samsung Biologics stands as a potential beneficiary of the enlarged pipeline.
Visa Eliminates 2,600 Jobs as AI Reshapes Payments: What Investors Need to Know
Visa announced 2,600 layoffs (7% of workforce) on July 28, 2026, the same day it reported Q3 FY2026 net revenue of USD 11.6B (+14% YoY). CEO McInerney cited AI-driven efficiency; USD 563M severance charge booked. Value-Added Services surged 34% YoY to USD 3.8B. Wall Street consensus: Strong Buy, avg target USD 401.
S&P Global (SPGI) Q2 2026: Ratings, Indices Power 23% EPS Beat as USD 7B Buyback Signals Confidence
S&P Global Q2 2026 earnings: Adj. EPS USD 4.83 (+23% YoY) beat USD 4.49 consensus by 7.6%. Ratings revenue +17%, Indices 13th consecutive record quarter (+20%). USD 7B buyback raised. SPGI stock fell ~5% as Mobility Global (MBGL) spin-off reshapes valuation.
August 7 U.S. Jobs Report: Why the Fed's 9-3 Split Makes Friday Critical for KOSPI Investors
Aug 7 BLS report arrives after the Fed's 9-3 split and June's 57K print. What Korean equity and currency investors need to watch Friday — KOSPI, KRW, Naver Q2.
AbbVie Q2 2026: SKYRIZI Matches Humira's Historic Peak as Apogee Deal Trims EPS Outlook
AbbVie beat Q2 2026 revenue estimates with USD 16.99B (+10.2%), driven by SKYRIZI matching Humira's all-time quarterly peak at USD 5.5B. Shares fell ~2% after the company trimmed full-year EPS guidance by USD 0.14/share to absorb the pending USD 10.9B Apogee Therapeutics acquisition, expected to close Q3 2026.
Korea Value-Up Program: 2026 Status, Index Performance, and What Investors Need to Know
741 Korean companies (85.5% mkt cap) enrolled. Value-Up Index ATH 3,977. Mar 2026 Act mandates treasury cancellations. MSCI upgrade path and investor guide.
Apple CEO John Ternus Takes Over September 1: What the Engineer Era Means for Korean Suppliers
Tim Cook hands Apple's CEO role to hardware engineer John Ternus on September 1. Here is what the leadership shift means for Samsung Display, SK Hynix, and LG Display.
Leidos (LDOS) Authorizes 20M-Share Buyback, Holds $0.43 Dividend as Q2 Earnings Test DOGE Recovery Thesis
Leidos (LDOS) declared a $0.43 quarterly dividend and authorized a new 20M-share buyback — exhausting its prior 2022 program — ahead of Q2 2026 results on August 4. With the stock down 34% over 52 weeks, analysts see 40% upside. DOGE's July shutdown may now reverse a key contract headwind.
Chevron (CVX) Q2 2026: Net Income Surges 384% to $12.1B on Record Production and $104 Oil
Chevron Q2 2026: net income +384% to $12.1B, adj. EPS $6.06 beats $5.57 consensus, record U.S. production 2.077 MBOED, and a 20-year 2.67 GW power deal with Microsoft. Adjusted FCF reached $15.4B in a single quarter.
LG Electronics Q2 2026: Q2-Record ₩1.57T OP (+147%) — NVIDIA AI Cooling Orders Exceed ₩600B
LG Electronics Q2 2026: Record revenue ₩23.83T (+14.9%), OP ₩1.57T (+147%). NVIDIA AI cooling orders ₩600B+ H1. Stock -10% on H2 freight headwinds and one-time tariff refund.